engin
recombin
r
modifi
vaccinia
ankara
mva
express
multipl
antigen
control
either
two
relat
vaccinia
synthet
promot
psyn
earli
late
transcript
activ
modifi
promot
predomin
earli
activ
sequenti
passag
construct
analyz
genet
stabil
qpcr
conclud
rmva
express
multipl
antigen
use
promot
exhibit
remark
genet
stabil
maintain
potent
immunogen
serial
passag
contrast
rmva
express
antigen
use
engin
vaccinia
synthet
el
psyn
ii
promot
genet
unstabl
progress
accumul
antigen
loss
variant
result
viral
prepar
lower
immunogen
serial
passag
metabol
label
follow
cold
chase
reveal
littl
differ
stabil
protein
express
psyn
promot
construct
conclud
mainten
genet
stabil
achiev
use
though
psyn
promot
link
time
magnitud
express
level
foreign
antigen
close
associ
immunogen
vaccin
modifi
vaccinia
ankara
highli
attenu
poxviru
propag
mammalian
cell
properti
minim
impact
viral
foreign
gene
express
mva
continu
replic
dna
concomit
robust
transcript
activ
life
cycl
interrupt
late
block
viral
assembl
addit
mva
larg
foreign
gene
capac
result
multipl
delet
creat
origin
develop
passag
chicken
embryo
fibroblast
cef
mva
wellestablish
safeti
record
histori
use
vaccin
viru
superior
properti
induc
potent
humor
cellular
immun
lead
mva
base
vaccin
treatment
infecti
diseas
cancer
success
enter
phase
iii
clinic
trial
mva
replic
dna
cytoplasm
cell
exclus
use
vaccinia
transcript
system
includ
promot
use
direct
foreign
antigen
gene
express
two
exampl
vaccinia
promot
wide
use
direct
foreign
gene
express
rmva
synthet
promot
psyn
contain
vaccinia
earli
late
promot
sequenc
optim
high
level
protein
express
modifi
promot
contain
nativ
earli
late
vaccinia
promot
region
psyn
stronger
overal
promot
activ
earli
activ
promot
threefiv
fold
stronger
psyn
seri
mva
viral
vector
virtu
includ
larg
foreign
gene
capac
multipl
integr
site
investig
genet
stabil
rmva
report
laboratori
develop
mva
viral
vector
deliv
antigen
mous
rhesu
macaqu
model
infecti
diseas
cancer
recent
gener
rmva
express
cmv
antigen
control
either
psyn
promot
viral
vector
promot
substanti
immunogen
either
evalu
vitro
propag
exist
cell
memori
popul
vivo
mous
model
primari
immun
report
demonstr
rmva
express
cmv
antigen
control
psyn
promot
genet
unstabl
serial
passag
howev
rmva
express
antigen
control
promot
exhibit
mark
genet
stabil
translat
compar
level
immunogen
extend
viru
passag
primari
cef
cell
prepar
specif
pathogenfre
chicken
egg
purchas
charl
river
spafa
north
franklin
ct
usa
cell
atcc
purchas
american
type
cell
collect
manassa
va
usa
maintain
minim
essenti
medium
mem
supplement
fetal
calf
serum
c
incub
contain
co
wild
type
wt
mva
viru
stock
transfer
plasmid
kindli
provid
dr
bernard
moss
laboratori
viral
diseas
niaid
nih
rmva
express
cmv
alon
togeth
control
psyn
promot
gener
laboratori
describ
previous
rmva
express
cmv
iefus
protein
control
psyn
promot
also
develop
via
homolog
recombin
method
pzwiia
transfer
vector
contain
two
psyn
promot
construct
describ
previous
addit
mva
transfer
plasmid
construct
replac
psyn
promot
first
replac
two
psyn
promot
pzwiia
one
promot
briefli
bp
dna
fragment
includ
bp
promot
sequenc
multipl
clone
site
synthes
genebank
access
clone
integr
dna
technolog
coralvil
ia
bp
dna
fragment
excis
xho
gel
purifi
clone
pzwiia
yield
modifi
replac
bacteri
gu
marker
gene
venu
tm
fluoresc
marker
gene
clontech
mountain
view
ca
usa
improv
speed
rmva
screen
cmv
gene
clone
yield
iefus
gene
clone
yield
mva
transfer
plasmid
use
gener
make
rmva
express
iefus
protein
simultan
new
mva
transfer
vector
contain
promot
target
mva
delet
iii
region
construct
base
plasmid
modifi
replac
origin
express
cassett
excis
xhoi
asci
site
insert
promot
follow
cmv
gene
yield
structur
mva
transfer
vector
verifi
restrict
enzym
digest
dna
sequenc
analysi
gener
transfect
wtmva
infect
cell
screen
base
venu
tm
fluoresc
marker
elimin
wtmva
accord
publish
procedur
gener
two
step
briefli
first
gener
transfect
cell
infect
wtmva
sixwel
plate
screen
elimin
wtmva
base
venu
tm
fluoresc
marker
express
expand
cell
round
screen
creat
stock
round
gene
insert
verif
wtmva
elimin
step
transfect
cell
simultan
infect
screen
base
bacteri
gu
gene
marker
round
parent
viru
remov
complet
expand
cell
creat
viru
stock
store
long
term
c
rmva
express
cassett
base
psyn
promot
consecut
passag
time
either
cef
cell
briefli
mm
tissu
cultur
dish
either
cef
cell
infect
rmva
moi
multipl
infect
rmva
harvest
h
infect
resuspend
ml
mem
contain
fetal
calf
serum
subject
freezethaw
cycl
follow
sonic
releas
viru
viru
passag
subsequ
titrat
either
cef
cell
adjust
moi
use
next
passag
dna
sampl
passag
obtain
qpcr
analysi
use
qiagen
tm
column
purif
kit
accord
manufactur
instruct
valencia
ca
usa
cell
lysat
passag
use
western
blot
wb
analysi
prepar
mm
dish
either
cef
cell
infect
number
pfu
rmva
serial
passag
order
character
viru
plaqu
passag
individu
plaqu
isol
viru
stock
plaqu
purif
briefli
viru
stock
psyn
titrat
immunostain
use
antivaccinia
polyclon
sera
abd
serotech
raleigh
nc
usa
dilut
distribut
pfu
per
well
plate
day
postinfect
well
appear
infect
one
viru
isol
collect
expand
analyz
wb
express
level
also
randomli
isol
individu
plaqu
use
method
protein
express
level
iefus
gene
infect
cell
measur
wb
use
amersham
ecl
plu
tm
detect
kit
amersham
pharmacia
biotech
buckinghamshir
unit
kingdom
cell
lysat
separ
sdspage
gel
electrotransf
protein
gel
onto
pvdf
membran
biorad
hercul
ca
usa
blot
incub
purifi
mab
mab
mab
wash
incub
hrplabel
goat
antimous
polyclon
ab
accord
manufactur
instruct
amersham
pharmacia
biotech
determin
presenc
gene
individu
isol
southern
blot
sb
perform
briefli
mm
cultur
dish
cell
infect
individu
isol
moi
incub
c
h
mva
viral
genom
dna
isol
accord
describ
method
cell
homogen
ml
hypoton
buffer
mm
trishcl
ph
mm
kcl
follow
incub
unit
micrococc
nucleas
sigmaaldrich
st
loui
mo
usa
h
c
digest
cellular
dna
reaction
stop
ad
egta
glycolbi
n
n
n
n
tetraacet
acid
cell
lysat
treat
proteinas
k
h
c
releas
mva
viral
dna
extract
use
phenolchloroform
method
sb
mva
viral
dna
digest
pme
nhe
restrict
enzym
excis
kb
fragment
tabl
list
qpcr
primer
qpcr
primer
measur
iefus
mva
thymidin
kinas
tk
gene
design
base
standard
qpcr
condit
use
primer
express
softwar
version
abi
foster
citi
ca
usa
contain
foreign
gene
cassett
separ
agaros
gel
transfer
nylon
membran
filter
hybrid
plabel
dna
probe
specif
gene
expos
hyperfilm
amersham
bioscienc
piscataway
nj
usa
qpcr
measur
dna
copi
number
mva
viral
dna
extract
use
qiagen
qiamp
miniprep
kit
accord
manufactur
instruct
qiagen
valencia
ca
usa
plasmid
dna
use
gener
standard
curv
made
insert
iefus
gene
vector
contain
tk
gene
absolut
concentr
plasmid
measur
two
independ
mean
od
uv
spectrophotometri
fluorophorebas
method
use
quantit
tm
dsdna
kit
invitrogen
carlsbad
ca
usa
concentr
convert
plasmid
copi
use
molecular
weight
plasmid
dna
primer
measur
iefus
gene
mva
backbon
copi
design
base
standard
qpcr
condit
use
primer
express
softwar
version
appli
biosystem
inc
foster
citi
ca
usa
list
tabl
qpcr
perform
use
abi
realtim
pcr
system
power
sybr
green
master
mix
kit
abi
briefli
l
mva
genom
dna
amplifi
mixtur
l
contain
forward
revers
primer
sybr
green
contain
solut
thermal
cycl
condit
c
min
cycl
c
end
one
cycl
c
gene
copi
number
calcul
use
abi
sequenc
detect
system
softwar
sd
ratio
insert
cmv
gene
mva
backbon
ratio
cmv
gene
copi
numbermva
backbon
comput
copi
number
calcul
passag
human
peripher
blood
mononuclear
cell
pbmc
collect
citi
hope
donorapheresi
center
ficollpurifi
cyropreserv
c
human
blood
sampl
consid
discard
anonym
except
hla
b
type
inform
provid
investig
without
identifi
iv
pbmc
use
rmva
perform
accord
previous
describ
method
briefli
cryopreserv
pbmc
rapidli
thaw
cultur
cpga
odn
cpgb
odn
trilink
biotechnolog
san
diego
ca
usa
pbmc
infect
rmva
h
rad
use
apc
incub
autologu
pbmc
pbmc
harvest
postiv
incub
either
iefus
peptid
librari
h
presenc
brefeldin
wash
label
peconjug
fitcconjug
antibodi
fix
permeabil
cytofixcytoperm
bd
bioscienc
label
apcconjug
antibodi
stain
cell
analyz
facscanto
flow
cytomet
bd
bioscienc
comparison
pair
data
perform
use
student
ttest
base
twotail
procedur
p
valu
consid
signific
hhd
ii
mice
tg
hla
use
week
immun
bred
maintain
spf
condit
central
anim
care
facil
hhd
ii
mice
immun
pfu
purifi
rmva
intraperiton
ip
rout
spleen
remov
three
week
postimmun
stimul
vitro
one
week
use
simplifi
protocol
hlamatch
human
ebvlcl
antigen
present
cell
apc
load
either
relev
cmvctl
epitop
hlaa
cmvpeptid
librari
gml
made
laboratori
icc
use
measur
cell
stimul
splenocyt
accord
previous
describ
method
event
acquir
sampl
facscanto
tm
bd
bioscienc
san
jose
ca
usa
analysi
perform
use
fc
express
version
softwar
de
novo
ontario
canada
number
doubleposit
cell
express
percentag
tcell
popul
determin
either
earli
total
transcript
activ
psyn
promot
rmva
infect
cell
use
infect
cell
h
absenc
presenc
cytosin
arabinosid
arac
briefli
cell
seed
per
well
onto
plate
cell
infect
either
moi
absenc
presenc
gml
arac
incub
h
c
co
incub
infect
cell
harvest
lyse
ml
sdspage
load
buffer
mm
trishcl
ph
mm
sd
glycerol
bromophenol
blue
cell
lysat
separ
sdspage
gel
electrotransf
protein
gel
onto
pvdf
membran
biorad
hercul
ca
usa
blot
incub
purifi
mab
mab
sigmaaldrich
wash
incub
hrplabel
goat
antimous
ab
accord
manufactur
instruct
measur
protein
express
level
blot
incub
chemifluoresc
substrat
solut
ecl
plu
detect
kit
amersham
ca
scan
use
typhoon
tm
workstat
analyz
imagequ
tl
ge
healthcar
bioscienc
corp
piscataway
nj
usa
pc
ip
perform
base
modif
describ
method
briefli
subconflu
cultur
cef
cell
grown
plate
infect
moi
label
cell
wash
twice
pb
either
harvest
immedi
chase
rpmi
medium
fc
iscbioexpress
kaysvil
ut
usa
supplement
excess
unlabel
methionin
mm
cystein
mm
h
time
point
cell
immedi
pellet
lyse
ml
pb
contain
triton
sodium
deoxychol
sigma
st
loui
mo
usa
sd
presenc
proteas
inhibitor
cocktail
roch
nutley
nj
usa
supernat
ml
preclear
l
protein
agagaros
bead
santa
cruz
biotechnolog
h
sequenti
incub
g
purifi
mab
mab
follow
isotopespecif
mab
h
immun
complex
captur
incub
h
l
protein
ag
bead
immun
complex
bound
protein
ag
bead
wash
time
triton
pb
bound
protein
elut
boil
sd
mm
dtt
mm
sodium
phosphat
buffer
ph
sdspolyacryamid
gel
electrophoresi
page
sampl
buffer
protein
separ
sdspage
detect
autoradiographi
use
xomat
film
kodak
rochest
ny
usa
psyn
gener
use
pzwiia
transfer
plasmid
previous
describ
gene
express
cassett
integr
del
delet
integr
site
ii
mva
genom
via
homolog
recombin
shown
fig
viru
titer
measur
growth
rate
passag
measur
sequenti
passag
round
cef
signific
chang
found
viru
titer
growth
rate
serial
passag
data
shown
cell
lysat
passag
prepar
parallel
mm
cultur
dish
cell
infect
amount
viru
establish
titrat
cef
protein
level
progress
decreas
passag
significantli
reduc
ten
serial
passag
fig
constitut
express
mva
protein
also
probe
passag
lysat
use
mab
shown
fig
steadi
state
express
level
unchang
passag
evalu
serial
passag
also
carri
cef
similar
result
data
shown
hypothes
gradual
decreas
express
level
serial
passag
could
caus
genet
chang
result
nonexpress
viral
isol
test
hypothesi
individu
isol
obtain
passag
plaqu
purif
well
appear
cytopatholog
effect
cpe
collect
postinfect
viru
sampl
consid
singl
isol
equival
pfu
viru
distribut
well
viral
infect
collect
sampl
confirm
continu
viru
growth
viru
titrat
express
level
measur
discov
individu
isol
lost
express
fig
contrast
isol
individu
isol
similar
strong
level
express
data
shown
delet
gene
caus
loss
protein
express
individu
viru
isol
caus
loss
protein
express
investig
mutat
total
delet
gene
serial
passag
hypothes
respons
loss
protein
express
two
isol
full
express
level
two
isol
lost
protein
express
fig
two
isol
retain
express
fig
investig
wb
blot
perform
detect
protein
express
level
southern
blot
sb
detect
express
cassett
viral
dna
similarli
mab
specif
mva
viral
protein
use
probe
lysat
separ
wb
detect
endogen
viral
gene
express
control
viru
input
six
sampl
fig
iii
two
individu
isol
mva
viral
genom
dna
digest
restrict
enzym
excis
kb
fragment
gene
express
cassett
separ
agaros
gel
transfer
nylon
membran
filter
filter
hybrid
pradiol
dna
probe
specif
gene
expos
xray
film
note
lane
panel
b
two
individu
isol
select
randomli
passag
lane
panel
b
two
individu
isol
mark
asterisk
fig
express
lane
panel
b
two
individu
isol
mark
asterisk
fig
elev
express
level
maintain
express
also
express
similar
level
fig
contrast
two
isol
lost
express
also
coordin
lost
protein
express
fig
ii
interestingli
case
either
coordin
express
antigen
absenc
suggest
whole
cassett
either
maintain
inactiv
delet
mutat
protein
express
detect
contrast
express
mva
protein
remain
uniformli
unchang
fig
iii
sb
perform
detect
gene
establish
relationship
protein
express
level
presenc
gene
equal
amount
dna
viral
isol
digest
pme
dna
restrict
enzym
excis
gene
express
cassett
kb
detect
pradiolabel
dna
probe
gene
express
cassett
detect
two
individu
viru
isol
lane
fig
detect
two
viral
isol
also
lost
protein
express
lane
fig
del
ii
site
mva
analyz
dna
restrict
endonucleas
analysi
mva
genom
dna
pcr
use
seri
primer
target
surround
del
ii
region
found
gene
express
cassett
togeth
surround
mva
del
ii
region
absent
data
shown
possibl
exclud
two
nonexpress
mutant
contamin
wt
mva
viru
introduc
amplifi
serial
passag
use
addit
qpcr
primer
data
shown
isol
maintain
express
shown
fig
lane
test
see
repres
stabil
form
gene
viru
serial
passag
two
isol
sequenti
passag
addit
round
cef
discov
protein
express
still
decreas
conclus
addit
serial
passag
data
shown
result
demonstr
high
express
iso
fig
immunogen
passag
passag
immun
hhd
ii
mice
hla
splenocyt
hhd
ii
mice
immun
passag
passag
subject
iv
separ
either
peptid
load
blast
cell
one
week
iv
splenocyt
incub
mock
peptid
overnight
harvest
icc
describ
section
averag
level
produc
specif
cmv
epitop
xaxi
immun
mice
shown
yaxi
produc
tcell
mock
ic
procedur
subtract
error
bar
repres
sem
immun
mice
late
stabil
form
subject
delet
passag
investig
reduct
protein
express
impact
immunogen
expand
viru
stock
mous
immun
hhd
ii
mice
separ
immun
passag
strain
week
splenocyt
immun
respons
assess
icc
detect
express
immunodomin
hla
ctl
epitop
use
evalu
hla
cell
respons
found
statist
signific
diminut
produc
splenocyt
compar
immun
group
fig
sinc
progress
loss
protein
express
correl
delet
gene
express
cassett
kinet
loss
gene
qpcr
measur
help
explain
instabl
gene
cassett
genet
stabil
rmva
assess
comput
ratio
foreign
gene
insert
mva
backbon
copi
number
ratio
gene
insert
mva
backbon
initi
passag
normal
uniti
gradual
reduct
ratio
found
serial
passag
rmva
genom
retain
gene
insert
round
fig
measur
establish
correl
loss
antigen
gene
confirm
qpcr
lower
protein
express
level
reduc
immunogen
passag
viral
popul
construct
rmva
express
three
cmv
antigen
control
two
separ
psyn
promot
expand
represent
earli
gene
epitop
divers
includ
gene
fuse
serial
passag
five
time
even
fig
genet
stabil
serial
passag
determin
qpcr
genom
dna
extract
describ
section
plasmid
contain
cmv
gene
use
prepar
absolut
standard
qpcr
perform
use
primer
specif
tk
gene
copi
number
gene
gene
mva
backbon
copi
calcul
use
abi
softwar
genet
stabil
determin
comput
ratio
gene
insert
mva
backbon
ratio
gene
insert
mva
backbon
indic
yaxi
ratio
passag
normal
consecut
passag
normal
base
passag
qpcr
dna
sampl
perform
three
time
independ
duplic
averag
ratio
error
bar
shown
figur
repres
three
independ
determin
b
viral
genom
dna
extract
qpcr
perform
use
iefuson
tk
specif
primer
describ
section
copi
number
gene
iefus
gene
mva
backbon
analyz
use
abi
softwar
genet
stabil
determin
comput
ratio
gene
insert
mva
backbon
ratio
iefus
gene
insert
mva
backbon
ratio
passag
gene
normal
qpcr
dna
sampl
perform
three
time
independ
duplic
averag
ratio
error
bar
shown
figur
repres
three
independ
determin
singl
passag
evid
instabl
observ
fig
origin
level
iefus
insert
sequenc
detect
qpcr
passag
demonstr
unexpect
decreas
stabil
fig
result
highlight
differ
combin
gene
iefus
result
pronounc
genet
instabl
use
psyn
promot
suggest
gene
main
contributor
genet
instabl
compar
activ
psyn
promot
hypothes
instabl
due
properti
psyn
promot
psyn
promot
optim
high
level
protein
express
design
highli
activ
combin
sever
earli
late
promot
element
domin
late
stage
promot
activ
improv
genet
stabil
psyn
promot
replac
promot
stimul
greater
proport
transcript
activ
earlier
stage
viru
life
cycl
fig
rmva
gener
use
shuttl
plasmid
promot
direct
transcript
gene
data
shown
quantif
qpcr
reveal
signific
chang
ratio
cmv
insert
genemva
backbon
genom
copi
number
serial
passag
viru
use
promot
direct
recombin
protein
express
fig
proceed
construct
singl
rmva
simultan
express
iefus
protein
use
dual
promot
evalu
two
differ
strategi
strategi
mva
express
three
antigen
construct
target
singl
integr
site
del
ii
plasmid
shuttl
vector
tandem
promot
oppos
orient
data
shown
could
stabli
prepar
possibl
due
intramolecular
homolog
recombin
presum
initi
ident
promot
copi
data
shown
second
strategi
iefus
gene
insert
two
separ
site
mva
del
ii
locat
del
iii
locat
mva
genom
prevent
delet
recombin
mediat
two
ident
copi
promot
schemat
pictur
structur
rmva
insert
site
shown
fig
viru
success
construct
passag
time
similar
manner
done
psyn
virus
fig
b
passag
conduct
fig
cef
fig
genet
stabil
evalu
qpcr
use
primer
pair
specif
iefus
gene
mva
viral
genom
backbon
respect
qpcr
result
cmv
antigen
comput
ratio
viral
genom
mva
backbon
fig
excel
stabil
found
cmv
gene
insert
del
ii
iii
integr
site
almost
gene
copi
number
maintain
passag
compar
fig
similar
result
found
viru
passag
cef
use
mva
backbon
sequenc
target
qpcr
fig
result
suggest
choic
cell
line
minor
insignific
compon
find
enhanc
stabil
mva
virus
use
promot
sinc
target
sequenc
measur
qpcr
repres
small
region
bp
kb
iefus
gene
kb
insert
result
may
repres
focus
region
instabl
throughout
entir
length
gene
exclud
possibl
sever
addit
pair
primer
target
differ
region
iefus
gene
design
found
ratio
iefus
compar
mva
genom
dna
backbon
similar
throughout
length
insert
gene
data
shown
evalu
genet
stabil
multipl
passag
translat
equival
immunogen
passag
assess
capac
passag
viral
stock
support
vigor
amplif
memori
cell
respons
exposur
human
pbmc
mva
vaccin
equival
immunogen
passag
p
ns
student
ttest
fig
observ
qualit
differ
cell
subset
pbmc
four
healthi
volunt
qpcr
determin
genet
stabil
serial
passag
viral
genom
dna
extract
qpcr
perform
use
tk
specif
primer
describ
section
copi
number
gene
mva
backbon
analyz
use
abi
softwar
genet
stabil
determin
comput
ratio
gene
insert
mva
backbon
ratio
passag
normal
qpcr
dna
sampl
perform
three
time
independ
duplic
averag
ratio
error
bar
shown
figur
repres
three
tabl
earli
late
activ
psyn
promot
measur
quantit
western
blot
cell
infect
moi
either
presenc
absenc
arac
infect
cell
harvest
h
postinfect
lyse
sdspage
load
buffer
blot
incub
first
purifi
mab
mab
hrplabel
goat
antimous
ab
protein
express
measur
scan
blot
use
typhoon
workstat
analyz
use
imagequ
softwar
use
intern
control
lane
number
shown
rel
level
signal
strength
use
arbitrari
scale
insert
gene
express
express
ratio
arac
stimul
individu
cmv
antigen
alter
passag
also
signific
differ
p
pair
test
respons
hhdii
mice
immun
mva
viru
stock
passag
similar
design
experi
shown
fig
high
level
cmv
cell
found
confirm
equival
viral
passag
elicit
highlevel
immunogen
immun
mice
fig
hypothes
stronger
earli
transcript
activ
promot
compar
psyn
promot
could
contribut
improv
genet
stabil
rmva
maintain
immunogen
arac
cytosin
deoxycytidin
analog
incorpor
dna
inhibit
dna
replic
form
cleavag
complex
topoisomeras
result
dna
fragment
select
inhibitor
dna
synthesi
affect
rna
synthesi
mammalian
cell
use
distinguish
earli
late
protein
express
cell
time
transcript
activ
psyn
promot
quantit
wb
employ
use
intern
standard
compar
express
level
lysat
cell
infect
either
absenc
presenc
arac
absenc
arac
similar
protein
express
level
observ
cell
howev
presenc
arac
remark
higher
level
express
cell
infect
versu
cell
infect
earli
express
account
total
earli
express
constitut
total
protein
tabl
effect
arac
psyn
promot
consist
earlier
studi
independ
determin
c
qpcr
determin
genet
stabil
serial
passag
genom
dna
extract
qpcr
perform
use
iefus
tk
specif
primer
describ
section
copi
number
gene
iefus
gene
mva
backbon
analyz
use
abi
softwar
genet
stabil
determin
comput
ratio
gene
insert
mva
backbon
ratio
iefus
gene
insert
mva
backbon
ratio
passag
gene
normal
similar
c
except
serial
passag
conduct
cef
shown
result
comput
use
tkspecif
primer
qpcr
dna
sampl
perform
three
time
independ
duplic
ratio
error
bar
shown
figur
present
averag
three
independ
determin
fig
immunogen
passag
use
human
pbmc
hhd
ii
mice
hla
immunogen
passag
use
human
pbmc
pbmc
healthi
donor
ex
vivo
posit
respond
cmv
antigen
incub
antigen
present
cell
infect
either
passag
passag
day
follow
overnight
incub
diluent
mock
peptid
librari
presenc
brefeldin
cell
harvest
stain
antihuman
mab
permeabil
stain
antihuman
mab
evalu
flow
cytometri
averag
percentag
produc
lymphocyt
shown
n
error
bar
repres
standard
deviat
b
immunogen
passag
hhd
ii
mice
hla
splenocyt
hhd
ii
mice
immun
passag
passag
subject
iv
separ
either
peptid
peptid
librari
load
hlaa
ebvlymphoblastoid
cell
lcl
deriv
healthi
cmv
posit
volunt
day
iv
splenocyt
incub
mock
peptid
peptid
librari
overnight
harvest
icc
describ
section
averag
level
tcell
product
specif
cmv
epitop
peptid
librari
shown
xaxi
immun
mice
product
mock
stimul
cell
ic
procedur
subtract
error
bar
repres
sem
immun
mice
pulsechas
analysi
reveal
equal
protein
stabil
antigen
control
either
psyn
promot
explor
altern
explan
profound
differ
stabil
mva
virus
util
psyn
promot
origin
demonstr
reduct
specif
signal
protein
band
fig
reduct
express
might
explain
differenti
protein
stabil
psyn
promot
use
rather
time
express
propos
base
experi
shown
tabl
consequ
use
approach
metabol
radiolabel
mvainfect
cef
fig
cell
data
shown
follow
cold
chase
measur
disappear
radiolabel
protein
measur
stabil
degrad
approach
close
follow
previou
work
use
vv
express
util
time
point
cold
chase
h
time
frame
suffici
measur
differ
protein
stabil
base
prior
work
infect
condit
cef
cell
close
follow
analysi
protein
express
fig
chang
label
limit
h
chase
minim
declin
h
time
point
promot
construct
fig
pattern
express
stabil
equival
either
psyn
construct
evalu
specif
recognit
radiolabel
shown
absenc
equival
radiolabel
band
gusmva
infect
control
lane
similar
prior
studi
use
vv
express
two
close
juxtapos
band
found
ip
mab
base
differ
decay
profil
nonspecif
band
prior
studi
lower
band
reflect
bonafid
protein
upper
band
like
contamin
moreov
examin
extract
use
isotyp
control
mab
show
absolut
specif
protein
data
shown
conclud
choic
promot
dramat
influenc
degrad
rate
antigen
consequ
protein
stabil
like
factor
determin
stabil
characterist
mva
express
purpos
studi
determin
relationship
protein
express
stabil
vector
stabil
immunogen
rmva
viral
stock
sequenti
passag
rmva
express
foreign
antigen
gene
evalu
clinic
vaccin
candid
infecti
diseas
cancer
genet
stabil
recombin
viru
major
concern
viral
vector
base
vaccin
intend
clinic
investig
lane
virus
use
infect
primari
cef
plate
mm
tc
dish
moi
h
follow
deplet
intracellular
store
met
cy
h
label
met
cy
addit
min
excess
unlabel
met
cy
dilut
fresh
medium
incub
time
indic
hour
gel
profil
conclus
chase
period
cell
lysat
made
immunoprecipit
conduct
describ
section
antigen
detect
mab
indic
arrow
right
adjac
gel
profil
lane
far
left
con
repres
control
cef
cultur
radiolabel
infect
gusmva
viru
express
bacteri
marker
without
must
amplifi
multipl
time
reach
scale
need
cgmp
manufactur
process
vector
must
retain
potenc
fulfil
expect
regulatori
agenc
includ
fda
requir
manufactur
process
irrevoc
alter
viru
structur
potenc
vaccin
studi
stabil
serial
passag
investig
data
show
protein
express
level
decreas
significantli
latter
passag
especi
reduct
express
like
caus
genet
chang
rmva
result
nonexpress
variant
lost
entir
gene
express
cassett
sequenti
passag
addit
found
later
passag
psyncontain
virus
reduc
immunogen
measur
use
assay
hhd
ii
mice
attribut
reduc
immunogen
popul
virus
fewer
clone
still
express
compar
earlier
passag
consist
previou
report
vitro
express
level
recombin
antigen
mva
vaccin
specif
hiv
correl
immunogen
exampl
viral
vector
stabil
passag
influenc
recombin
insert
observ
exampl
includ
coronavirus
west
nile
viru
replicon
potexviru
lister
strain
anoth
poxviru
member
therefor
evalu
genet
stabil
rmva
express
cmv
viral
gene
use
altern
promot
found
promot
improv
genet
stabil
insert
gene
rmva
maintain
potent
immunogen
extend
viru
passag
genet
stabil
recombin
viru
assess
sever
mean
includ
wb
detect
foreign
protein
express
level
passag
immunostain
viru
plaqu
calcul
percentag
foreign
protein
produc
foci
serial
passag
although
method
technic
simpl
labor
intens
qpcr
method
develop
measur
genet
stabil
sensit
highthroughput
reproduc
prior
approach
use
taqman
assay
also
adapt
stabil
test
genet
stabil
defin
comput
ratio
foreign
protein
gene
mva
genom
backbon
gene
copi
passag
correl
foreign
insert
protein
express
level
passag
data
shown
qpcr
use
demonstr
unstabl
insert
gene
copi
remain
passag
even
highli
unstabl
iefus
gene
copi
remain
five
consecut
passag
molecular
mechan
genet
instabl
rmva
use
psyn
promot
improv
genet
stabil
use
promot
yet
fulli
investig
caus
instabl
rmva
might
due
high
protein
express
level
lead
toxic
gene
product
cell
infect
rmva
sinc
psyn
promot
optim
highest
attain
level
transcript
activ
howev
metabol
radiolabel
follow
cold
chase
establish
equival
stabil
antigen
express
either
psyn
promot
construct
passag
conclus
must
temper
fact
complet
exclud
properti
insert
may
contribut
vector
genet
instabl
unpredict
way
instanc
combin
gene
use
singl
integr
site
evalu
use
psyn
promot
fulli
reconstruct
use
promot
howev
observ
even
greater
instabl
iefus
gene
replac
sequenc
context
psyn
promot
contrast
observ
mark
instabl
gene
product
examin
report
context
promot
although
combin
gene
insert
site
ident
compar
psyn
seri
similar
problem
note
other
regard
hivenv
measl
viru
f
protein
express
mva
case
toxic
express
protein
contribut
genet
instabl
rmva
express
report
rmva
express
hemagglutininneuraminidas
hn
glycoprotein
control
vaccinia
psyn
promot
replic
poorli
due
toxic
level
gene
product
rmva
express
f
hn
gene
control
psyn
replic
poorli
wherea
rmva
express
gene
control
promot
replic
high
titer
cef
cell
due
less
express
hn
genet
stabil
rmva
enhanc
reduc
express
level
hn
glycoprotein
previou
report
suggest
rmva
instabl
relat
genom
posit
insert
foreign
protein
gene
exampl
rmva
tat
gagpol
gene
insert
intergen
region
mva
show
loss
stabil
express
mani
passag
recent
explor
express
genet
stabil
intergen
region
site
insert
ident
gene
cassett
includ
promot
shown
fig
region
mva
genom
obtain
excel
express
level
stabil
rival
found
shown
fig
conclus
promot
qualiti
earli
time
moder
express
level
critic
vector
stabil
howev
protein
toxic
probabl
import
factor
sever
integr
site
impart
similar
level
stabil
rmva
recombin
viru
found
rmva
express
cmv
viral
protein
use
psyn
promot
grow
replic
high
titer
cef
cell
data
shown
quantit
wb
result
indic
protein
express
level
similar
promot
cassett
driven
either
psyn
suggest
instabl
rmva
use
psyn
promot
associ
protein
express
level
genet
stabil
rmva
use
promot
improv
reduct
protein
express
level
exclud
compon
instabl
mayb
impart
choic
cell
line
select
case
sinc
directli
compar
everi
construct
cell
line
case
compar
stabil
cef
substanti
differ
found
attribut
cell
line
result
quantit
wb
indic
earli
express
sevenfold
stronger
control
compar
psyn
promot
consequ
time
express
magnitud
hypothes
mechan
explain
increas
genet
stabil
rmva
use
promot
report
select
number
gene
product
investig
therefor
conclus
drawn
result
gener
gene
product
evalu
manner
conduct
evalu
howev
new
find
exclud
mechan
promot
enhanc
genet
stabil
rmva
decreas
late
express
toxic
protein
promot
import
consider
vaccin
design
improv
genet
stabil
maintain
immunogen
rmva
develop
clinic
applic
recommend
sever
other
recent
publish
base
upon
experi
hiv
antigen
insert
delet
site
intergen
region
like
thank
dr
linda
wyatt
bernard
moss
niaid
wt
mva
plasmid
vector
construct
rmva
also
like
thank
dr
f
lemonni
hhd
ii
mice
mta
institut
pasteur
pari
franc
mab
kind
gift
dr
g
griffith
karolinska
institut
dr
wyatt
moss
acknowledg
technic
assist
aparna
krishnan
heang
ly
secretari
administr
assist
donna
packer
denis
marsano
manuscript
editori
assist
keeli
walker
grate
acknowledg
support
staff
citi
hope
donorapheresi
center
assist
human
sampl
prepar
citi
hope
anim
research
center
